This commentary from Diabeticinvestor is worth a read on Lifescan's positioning in the CGM market:
https://diabeticinvestor.com/a-path-to/
Emphasizes the scale of Lifescan's customer base as being vital in the competitive CGM market - all good news for Sensera if we can get that sensor to Sanvita medical.
- Forums
- ASX - By Stock
- SE1
- Continuous Glucose Monitor
Continuous Glucose Monitor, page-83
Featured News
Add SE1 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online